A financial backer of the effort to legalize the drug MDMA for therapeutic use sees the potential for "exponential growth" should it win approval from the.
By Chris Wack Pasithea Therapeutics said it has received Investigational New Drug Application clearance to proceed by the Federal Drug Administration to.
This year’s rollout marks a definitive transition to a commercial market for the vaccines, which had previously been purchased by the U.S. government..